Heterogeneous cancer‐associated fibroblasts: A new perspective for understanding immunosuppression in pancreatic cancer.

MLA

Zhang, Zhilin, et al. “Heterogeneous Cancer‐associated Fibroblasts: A New Perspective for Understanding Immunosuppression in Pancreatic Cancer.” Immunology, vol. 167, no. 1, Sept. 2022, pp. 1–14. EBSCOhost, https://doi.org/10.1111/imm.13496.

APA

Zhang, Z., Zhang, H., Shi, L., Wang, D., & Tang, D. (2022). Heterogeneous cancer‐associated fibroblasts: A new perspective for understanding immunosuppression in pancreatic cancer. Immunology, 167(1), 1–14. https://doi.org/10.1111/imm.13496

Chicago

Zhang, Zhilin, Huan Zhang, Lin Shi, Daorong Wang, and Dong Tang. 2022. “Heterogeneous Cancer‐associated Fibroblasts: A New Perspective for Understanding Immunosuppression in Pancreatic Cancer.” Immunology 167 (1): 1–14. doi:10.1111/imm.13496.